elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q62063038-F0CFC740-709D-46ED-A5FA-F9BD404A43ED
Q62063038-F0CFC740-709D-46ED-A5FA-F9BD404A43ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q62063038-F0CFC740-709D-46ED-A5FA-F9BD404A43ED
Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL
P8005
Q62063038-F0CFC740-709D-46ED-A5FA-F9BD404A43ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q62063038-F0CFC740-709D-46ED-A5FA-F9BD404A43ED
rank
NormalRank
type
BestRank
Statement
P8005
not yet recruiting